Drug Profile
Anti-CD2 monoclonal antibody RM2-4
Alternative Names: RM2-4; RM2-4 monoclonal antibodyLatest Information Update: 11 Nov 2003
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Monoclonal antibodies
- Mechanism of Action CD2 antigen inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Transplant rejection
Most Recent Events
- 11 Nov 2003 Discontinued - Preclinical for Transplant rejection in USA (unspecified route)
- 14 Jul 1998 No-Development-Reported for Transplant rejection in USA (Unknown route)
- 15 Dec 1995 Preclinical development for Transplant rejection in USA (Unknown route)